Kevzara subcutaneous injection 150mg syringe, manufactured by Sanofi, contains Sarilumab (genetical recombination) (YJ code: 3999444G1022, 150mg 1.14mL 1 tube). This interleukin-6 (IL-6) receptor antagonist is used to treat moderately to severely active rheumatoid arthritis in adults who have not adequately responded to other disease-modifying antirheumatic drugs (DMARDs).
Kevzara subcutaneous injection 150mg syringe
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →